PROM1 and glioblastoma: Tumors were generated after stereotaxic implantation of glioblastoma CD133+ cells labeled with MION-Rh (Figure 5B), and the progression of tumor growth was monitored by using combined fluorescence and X-ray detection (Figure 5C, 5D).